Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  recombinant interferon alfa
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Recombinant Interferon Alpha-2a and Sargramostim or Vaccine Therapy in Treating Patients with Chronic Phase Chronic Myelogenous Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J05121, NCI-2011-00392, CDR0000492005, JHOC-J05121, NA_00001887, NCT00363649
Natural History of Recombinant Interferon Alfa-2B or Combination Chemotherapy and Rituximab in Treating Patients with Grade I-III Lymphomatoid Granulomatosis
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Age: 12 and over
Trial IDs: 94-C-0074, NCI-2013-01582, 940074, MB-325, NCT00018993, NCT00001379
An Observational Study to Compare the Compliance With Toxicity of Standard High-Dose Interferon A Versus Sylatron
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Merck MISP 50422, NCI-2015-01266, NCT01986712
Start Over